A team of researchers from the Icahn School of Medicine at Mount Sinai and Keck School of Medicine at the
Home ยป
New subtype of prostate cancer: Tumors with alterations in the CDK12 gene were more responsive to immunotherapy, suggesting precision medicine approach
Researchers led by the University of Michigan Rogel Cancer Center have identified a new subtype of prostate cancer that occurs
Genome’s dark matter offers clues to major challenge in prostate cancer: Researchers identify a lncRNA that provides insight into a key driver of prostate cancer — and a potential target for future therapy
The dark matter of the human genome may shed light on how the hormone androgen impacts prostate cancer. Researchers at